Risk factors of acute graft-versus-host disease (AGVHD) after allogeneic bone marrow transplantation using an matched unrelated donor (MUD) and prophylaxis with taclorimus (FK506) and methotrexate (MTX)

被引：0
|
作者：
Iguchi, T
Okamoto, S
Mori, T
Watanabe, R
Sato, N
Nagayama, H
Takayama, N
Ikeda, Y
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P654
引用
收藏
页码：S172 / S173
页数：2
相关论文
共 50 条
  • [1] Tacrolimus (FK506) combined with methotrexate (MTX) is effective in preventing acute graft versus host disease (AGVHD) following related donor allogeneic bone marrow transplantation (BMT).
    Devine, SM
    Geller, RB
    Dix, SP
    Connaghan, DG
    Fleming, WH
    Heffner, LT
    Hillyer, CD
    Holland, HK
    Waller, EK
    Winton, EF
    Wingard, JR
    BLOOD, 1995, 86 (10) : 1569 - 1569
  • [2] FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors
    Nash, RA
    Pineiro, LA
    Storb, R
    Deeg, HJ
    Fitzsimmons, WE
    Furlong, T
    Hansen, JA
    Gooley, T
    Maher, RM
    Martin, P
    McSweeney, PA
    Sullivan, KM
    Anasetti, C
    Fay, JW
    BLOOD, 1996, 88 (09) : 3634 - 3641
  • [3] Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
    G Yanik
    JE Levine
    V Ratanatharathorn
    R Dunn
    J Ferrara
    RJ Hutchinson
    Bone Marrow Transplantation, 2000, 26 : 161 - 167
  • [4] Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
    Yanik, G
    Levine, JE
    Ratanatharathorn, V
    Dunn, R
    Ferrara, J
    Hutchinson, RJ
    BONE MARROW TRANSPLANTATION, 2000, 26 (02) : 161 - 167
  • [5] Mycophenolate mofetil, cyclosporine and methotrexate as acute graft versus host disease prophylaxis after matched unrelated donor allogeneic bone marrow transplantation.
    Huang, H
    Lin, MF
    Lee, ZD
    Meng, HT
    Qian, WB
    Yan, LX
    Cai, Z
    BLOOD, 2000, 96 (11) : 361B - 361B
  • [6] Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation
    A Hiraoka
    Y Ohashi
    S Okamoto
    Y Moriyama
    T Nagao
    Y Kodera
    A Kanamaru
    H Dohy
    T Masaoka
    Bone Marrow Transplantation, 2001, 28 : 181 - 185
  • [7] Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation
    Hiraoka, A
    Ohashi, Y
    Okamoto, S
    Moriyama, Y
    Nagao, T
    Kodera, Y
    Kanamaru, A
    Dohy, H
    Masaoka, T
    BONE MARROW TRANSPLANTATION, 2001, 28 (02) : 181 - 185
  • [8] PREVENTION OF GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION IN RATS USING FK506
    MARKUS, PM
    XIN, C
    WEI, M
    DEMETRIS, AJ
    FUNG, JJ
    STARZL, TE
    TRANSPLANTATION, 1991, 52 (04) : 590 - 594
  • [9] FK506 THERAPY FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENIC BONE-MARROW TRANSPLANTATION
    MASAOKA, T
    HIRAOKA, A
    KANAMARU, A
    DOHY, H
    KODERA, Y
    MORIYAMA, Y
    OKAMOTO, S
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 864 - 864
  • [10] FK506 IN COMBINATION WITH METHOTREXATE (MTX) FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM PHENOTYPICALLY HLA-IDENTICAL UNRELATED DONORS
    NASH, RA
    MCSWEENEY, PA
    STORB, R
    GOOLEY, T
    FURLONG, T
    APPELBAUM, F
    DEEG, HJ
    DONEY, K
    MARTIN, P
    SULLIVAN, K
    WITHERSPOON, R
    ZAGER, RA
    HANSEN, JA
    ANASETTI, C
    BLOOD, 1994, 84 (10) : A394 - A394
12345